Source: Annual Congress 2007 - COPD and comorbidity
Disease area: Airway diseases



Rating:

Share or cite this content

Citations should be made in the following way:
T. Brodskaya, V. Nevzorova, B. Geltser, E. Motkina (Vladivostok, Russian Federation). Arterial stiffness in COPD patients is associated with hypoxemia and plasma nitric oxide level. Eur Respir J 2007; 30: Suppl. 51, 4148

Member's Comments

No comment yet.

Related content which might interest you: Arterial stiffening in asthma exacerbation is connected with systemic inflammation, oxidative disbalance, hypoxemia and nitric oxide plasma level Source: Eur Respir J 2007; 30: Suppl. 51, 552s Year: 2007 Profiling nitric oxide metabolites in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2016; 48: 1386-1395 Year: 2016 Hyperinflation is associated with reduced nitric oxide production in COPD Source: Eur Respir J 2005; 26: Suppl. 49, 226s Year: 2005 Increased eNO and pulmonary iNOS expression in eNOS null mice Source: Eur Respir J 2003; 21: 770-773 Year: 2003 Nitric oxide metabolite flux during exercise in pulmonary arterial hypertension Source: Annual Congress 2011 - Physiology of human pulmonary hypertension Year: 2011 Exhaled nitric oxide levels in patients with pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Persistently elevated exhaled nitric oxide fraction is associated with increased risk of exacerbation in COPD Source: Eur Respir J, 51 (1) 1701457; 10.1183/13993003.01457-2017 Year: 2018 The effect of inhaled nitric oxide on the cardiac performance in patients with hypoxic pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 269s Year: 2003 Correlation of inhaled nitric-oxide induced reduction of pulmonary artery pressure and vascular changes Source: Eur Respir J 2002; 20: 52-58 Year: 2002 Influence of inhaled nitric oxide on plasma endothelin-1 in pulmonary hypertension Source: Eur Respir J 2003; 22: Suppl. 45, 463s Year: 2003 Exhaled nitric oxide in patients with idiopathic pulmonary fibrosis and pulmonary hypertension Source: Annual Congress 2008 - Management of idiopathic pulmonary fibrosis: what can we learn from the pathophysiology? Year: 2008 Fractional exhaled nitric oxide in patients with chronic obstructive pulmonary disease Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification Year: 2019 Effect of the Asp298 variant of endothelial nitric oxide synthase on acute pulmonary vasodilator testing response in idiopathic pulmonary arterial hypertension Source: Eur Respir J 2006; 28: Suppl. 50, 547s Year: 2006 Exhaled condensate of endothelin-1 and exhaled nitric oxide are increased in COPD patients with secondary pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 55s Year: 2007 Changes in nitric oxide production in patients with COPD Source: Eur Respir J 2006; 28: Suppl. 50, 190s Year: 2006 Tolerance of long term nitric oxide treatment in severe arterial pulmonary hypertension Source: Eur Respir J 2002; 20: Suppl. 38, 370s Year: 2002 Nocturnal symptoms in asthma are related to increased alveolar nitric oxide concentration Source: Eur Respir J 2002; 20: Suppl. 38, 6s Year: 2002 Haemodynamic testing in primary pulmonary hypertension - effects of nitric oxide, iloprost and oxygen Source: Eur Respir J 2001; 18: Suppl. 33, 414s Year: 2001 Endothelin system, exhaled nitric oxide and high altitude pulmonary hypertension Source: Eur Respir J 2007; 30: Suppl. 51, 551s Year: 2007 Replacement of physiologically autoinhaled nitric oxide in intubated patients Source: Eur Respir J 2003; 21: 677-681 Year: 2003